AGILON HEALTH INC (AGL) Stock Overview
NYSE:AGL - US00857U1079 - Common Stock
AGL Key Statistics, Chart & Performance
The current stock price of AGL is 1.15 USD. In the past month the price increased by 33.21%. In the past year, price decreased by -67.42%.
AGL Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.55 | 92.88B | ||
| CI | THE CIGNA GROUP | 10.69 | 80.17B | ||
| LH | LABCORP HOLDINGS INC | 18.11 | 22.78B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.12 | 20.23B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 129.78 | 17.01B | ||
| FMS | FRESENIUS MEDICAL CARE-ADR | 12.19 | 14.59B | ||
| HIMS | HIMS & HERS HEALTH INC | 63.43 | 11.47B | ||
| DVA | DAVITA INC | 13.86 | 9.61B | ||
| GH | GUARDANT HEALTH INC | N/A | 7.22B | ||
| CHE | CHEMED CORP | 20.27 | 6.61B | ||
| RDNT | RADNET INC | 201.39 | 5.58B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 38.01 | 4.98B |
Related stock screener links
About AGL
Company Profile
Agilon Health, Inc. engages in providing healthcare services. The company is headquartered in Austin, Texas and currently employs 1,076 full-time employees. The company went IPO on 2021-04-15. The company enables primary care physicians (PCP) to be the agents for change in the communities they serve. Through its combination of the agilon platform, a long-term partnership model with existing physician groups and a growing network of like-minded physicians, it offers healthcare for seniors across communities throughout the United States. Its model operates by primarily forming risk-bearing entities (RBEs) within local geographies, that enter into arrangements with payors providing for monthly payments to manage the total healthcare needs of its physician partners’ attributed patients (or global capitation arrangements). The company focuses on community-based physician groups and is built around three key elements: agilon’s platform, agilon’s long-term physician partnership approach, and agilon’s network. The agilon platform is holistic in supporting the rapid transition to a Total Care Model with technology, people, process and capital.
Company Info
AGILON HEALTH INC
6210 E Hwy 290, Suite 450
Austin TEXAS US
CEO: Steve Sell
Employees: 1076
Phone: 15622563800
AGILON HEALTH INC / AGL FAQ
What is the stock price of AGILON HEALTH INC today?
The current stock price of AGL is 1.15 USD.
What is the ticker symbol for AGILON HEALTH INC stock?
The exchange symbol of AGILON HEALTH INC is AGL and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is AGL stock listed?
AGL stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for AGILON HEALTH INC stock?
27 analysts have analysed AGL and the average price target is 2.02 USD. This implies a price increase of 75.49% is expected in the next year compared to the current price of 1.15. Check the AGILON HEALTH INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is AGILON HEALTH INC worth?
AGILON HEALTH INC (AGL) has a market capitalization of 476.58M USD. This makes AGL a Small Cap stock.
How many employees does AGILON HEALTH INC have?
AGILON HEALTH INC (AGL) currently has 1076 employees.
What are the support and resistance levels for AGILON HEALTH INC (AGL) stock?
AGILON HEALTH INC (AGL) has a resistance level at 1.78. Check the full technical report for a detailed analysis of AGL support and resistance levels.
Is AGILON HEALTH INC (AGL) expected to grow?
The Revenue of AGILON HEALTH INC (AGL) is expected to decline by -3.78% in the next year. Check the estimates tab for more information on the AGL EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy AGILON HEALTH INC (AGL) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of AGL, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of AGL, evaluating the profitability, health, valuation and growth aspects
- AGILON HEALTH INC (AGL) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- AGILON HEALTH INC (AGL) Sales and EPS estimates to see what analysts future expectations are.
- AGILON HEALTH INC (AGL) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- AGILON HEALTH INC (AGL) Insider and Institutional Ownership to learn about the owners and their transactions.
- AGILON HEALTH INC (AGL) Stock Chart to make your own analysis
- AGILON HEALTH INC (AGL) Latest news and press-releases to stay up to date.
Does AGILON HEALTH INC (AGL) stock pay dividends?
AGL does not pay a dividend.
When does AGILON HEALTH INC (AGL) report earnings?
AGILON HEALTH INC (AGL) will report earnings on 2025-11-05, after the market close.
What is the Price/Earnings (PE) ratio of AGILON HEALTH INC (AGL)?
AGILON HEALTH INC (AGL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.77).
What is the Short Interest ratio of AGILON HEALTH INC (AGL) stock?
The outstanding short interest for AGILON HEALTH INC (AGL) is 6.25% of its float. Check the ownership tab for more information on the AGL short interest.
AGL Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to AGL. When comparing the yearly performance of all stocks, AGL is a bad performer in the overall market: 98.11% of all stocks are doing better.
AGL Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to AGL. While AGL seems to be doing ok healthwise, there are quite some concerns on its profitability.
AGL Financial Highlights
Over the last trailing twelve months AGL reported a non-GAAP Earnings per Share(EPS) of -0.77. The EPS decreased by -35.09% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -18.43% | ||
| ROE | -77.19% | ||
| Debt/Equity | 0 |
AGL Forecast & Estimates
27 analysts have analysed AGL and the average price target is 2.02 USD. This implies a price increase of 75.49% is expected in the next year compared to the current price of 1.15.
For the next year, analysts expect an EPS growth of -3.02% and a revenue growth -3.78% for AGL